Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol., 25 June 2025

Sec. Clinical Diabetes

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1571488

This article is part of the Research TopicPrevention and Treatment Advancements in Diabetic RetinopathyView all 14 articles

Study on the prevalence of diabetic retinopathy in Pudong New Area and the predictive value of estimated glucose disposal rate: a cross-sectional study

Jiaojiao Gao&#x;Jiaojiao GaoKang Wu&#x;Kang WuXiaonan WangXiaonan WangZhitao LiZhitao LiXiaolin LiuXiaolin LiuJiahui SongJiahui SongYang LiuYang LiuHua QiuHua QiuFeng WeiFeng WeiQian XuQian XuShaotan XiaoShaotan XiaoYi Zhou*Yi Zhou*Xiaonan Ruan*Xiaonan Ruan*
  • Shanghai Pudong New Area Center for Disease Control and Prevention (Shanghai Pudong New Area Health Supervision Institute), Pudong Institute of Preventive Medicine of Fudan University, Shanghai, China

Objective: To describe the prevalence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM) in Pudong New Area, Shanghai, and to explore the association between estimated glucose disposal rate (eGDR) and DR, as well as the possibility of eGDR as a predictive marker.

Methods: Field investigation was conducted among sampled patients with T2DM from May to September 2023. Fundus examination was performed by automatic mydriatless fundus camera to evaluate the prevalence of DR. Restricted cubic spline (RCS) function was employed to evaluate the dose-response relationship between eGDR and DR. Logistic regression analysis was performed to examine their association.

Results: A total of 2,327 patients with T2DM completed the survey, with a median age of 69 years. The prevalence of DR in Pudong New Area was 7.39%, and RCS curve demonstrated a significant negative linear relationship between eGDR and DR. After controlling for confounding factors, the results of the logistics regression showed that the risk of DR decreased by 40.4% for every one standard deviation increase in eGDR. The area under the ROC curve for eGDR predicting DR was 0.777 and 0.781, indicating a high predictive value of eGDR for DR.

Conclusion: There is a significant negative linear association between eGDR and the risk of DR, and eGDR is expected to serve as a target for DR prediction and intervention.

1 Introduction

Diabetic retinopathy (DR) is the most common form of diabetic microangiopathy, with a global prevalence of approximately 22.27% (1). It has become the leading cause of blindness among the working-age population due to the visual impairment caused by diabetic macular edema (2). The analysis of the fundus disease spectrum revealed a significant increase in the prevalence of DR among individuals under 35 years of age between 2019 and 2021 (3). Previous research indicated patients with type 2 diabetes mellitus (T2DM) exhibited suboptimal adherence to recommended eye examinations, and a study conducted in Shanghai found that the average awareness level of DR in T2DM was only 12.37%, and the rate of fundus examination was only 12.34% (4, 5). The early symptoms of DR are insidious, with gradual pathological changes, making early detection and intervention particularly challenging. Thus, early fundus examination and research into the potential influencing factors of DR hold significant clinical value for enhancing the management quality of T2DM patients and preventing vision loss due to retinopathy.

Insulin resistance (IR) is a typical pathological change in T2DM, and studies have shown that IR significantly increases the risk of cardiovascular disease (6). Insulin measurement is invasive and costly, and recently some IR surrogate markers based on non-insulin detection have been developed. The estimated glucose disposal rate (eGDR), as an emerging indicator, is considered a reliable substitute for IR. Studies suggest that eGDR can serve as an intervention target to mitigate the risk of macrovascular disease, including cardiovascular events (7, 8). However, the relationship between eGDR and microvascular diseases, such as DR, is limited, and the association may be modified by gender and other characteristics (9, 10). Therefore, this study aims to analyze the current epidemiological status of DR among patients with T2DM in Pudong New Area, and to investigate the association between eGDR and DR, as well as the predictive value of eGDR for DR.

2 Materials and methods

2.1 Participants

A multi-stage stratified random cluster sampling method was employed to conduct a sampling survey on T2DM from May to September 2023. The inclusion criteria were: T2DM and living in Pudong New Area for more than 6 months. The exclusion criteria were: (1) Type 1 diabetes, gestational diabetes mellitus, and special types of diabetes; (2) Complications of acute diabetes, severe cardiovascular and cerebrovascular diseases, malignant tumors, and stress states; (3) Patients who have undergone vitrectomy or retinal laser photocoagulation; (4) Patients with unclear fundus images (9, 10). The sample size calculation formula for the current study is: n=pq(d/za)2, where p is the expected prevalence rate. Referring to previous studies, p was taken as 0.22 (1), α was set to 0.05, at which point zα was 1.96, and the common allowable error was 0.15p. Considering non-response bias, an additional 20% sample size was added, thus, the calculated sample size was approximately 736. The sample size of this survey meets the requirements.

2.2 Methods

2.2.1 Questionnaire

The self-designed questionnaire was determined by literature review and expert review, including (1) basic information: gender, age, marital status, education, family history, tobacco and alcohol use, living situation, sleep situation, physical activity; (2) blood sugar management and control: time of initial diabetes diagnosis, history of hypoglycemia in the past year, complications of diabetes.

2.2.2 Anthropometric measurements and assessments of glycosylated hemoglobin

(HbA1c) levels Height, weight, waist circumference, hip circumference, and blood pressure were measured on site and accurately recorded. HbA1c levels were measured using boronate affinity chromatography (brand: Sinocare, model: PCH-50) based on solid-phase immunoassay methodology, which determined the percentage of HbA1c relative to total hemoglobin.

2.2.3 Fundus examination

A fully automatic non-mydriatic fundus camera (brand: Airdoc, model: AI-FD16aF) was used for fundus examination of T2DM. DR was staged into non-proliferative DR and proliferative DR according to Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022) (11). Each eye was photographed separately, and if the severity of the lesions in both eyes was different, the more severe side was used for staging.

2.2.4 Sleep status survey

The Pittsburgh Sleep Quality Index (PSQI) was utilized to assess the sleep quality of participants over the past month. The total score ranges from 0 to 21, where a higher score signifies poorer sleep quality, and a score exceeding 7 indicates clinically significant sleep disturbances (12).

2.2.5 Assessment of cognitive function

The Montreal Cognitive Assessment Basic Scale (MoCA-B) (13) was utilized, with a maximum score of 30. For participants with different levels of education, the cutoff scores for Mild Cognitive Impairment (MCI) were set as follows: ≤ 19 for those with ≤ 6 years of education, ≤ 22 for those with 7–12 years of education, and ≤ 24 for those with more than 12 years of education.

2.2.6 Physical activity survey

The World Health Organization’s Global Physical Activity Questionnaire (GPAQ) was utilized to evaluate participants’ physical activity levels across work, transportation, and recreational domains, as well as their daily sedentary time (14). A metabolic equivalent of task score of 600 or higher per week indicated that the physical activity level met the recommended standard. According to self-reports, sitting or reclining for a total of more than 480 minutes per day was considered severe sedentary behavior (15).

2.2.7 Calculation of eGDR

The calculation formula for eGDR (mg/(kg·min)] is as follows: eGDR = 21.158 - [0.09 × waist circumference (cm)] - [3.407 × hypertension (yes/no)] - [0.551 × HbA1c (%)] (9). A lower eGDR indicates a diminished capacity of the body to process glucose and a higher degree of insulin resistance.

2.2.8 Ethical approval

This study was approved by the Medical Ethics Committee of Pudong New Area Center for Disease Control and Prevention, Shanghai (Approval No. PDCDCLL-20220718-001), and written informed consent was obtained from all participants.

2.3 Quality control

All investigators involved in the field investigation are certified practicing physicians from primary-level medical institutions. Prior to the investigation, all investigators undergo standardized training. Additionally, at least two personnel from the Centers for Disease Control and Prevention concurrently conduct quality control during each investigation.

2.4 Statistical methods

Data cleaning and statistical analysis were performed using SPSS 23.0 and SAS 9.1.3 software. Normality of continuous variables was assessed using the Kolmogorov-Smirnov test. Normally distributed measurement data were described using mean ± standard deviation (SD), while skewed distribution data were characterized by median (interquartile range). For normally distributed data with homogeneous variance, one-way ANOVA or independent two-sample t-tests were employed for comparisons. Chi-square tests were used for categorical data comparisons. Restricted cubic splines (RCS) were employed to evaluate the dose-response relationship between eGDR and DR. Logistic regression analysis was performed to examine their association, with Model 1 remaining unadjusted and Model 2 incorporating adjustments for confounding factors including family history, history of hypoglycemia, sleep disorders, mild cognitive impairment, and disease duration. The predictive performance of eGDR for DR was subsequently assessed through receiver operating characteristic (ROC) curve analysis. The eGDR values were categorized into three groups based on percentile distribution. Subgroup analyses were performed to confirm the robustness of the results (8, 9). All statistical tests were conducted at a significance level of α=0.05.

3 Results

3.1 Epidemiological status of DR in Pudong New Area

A total of 2327 T2DM patients were surveyed, comprising 1006 males and 1321 females. The median age was 69 years (interquartile range: 63–74 years), and the median duration of diabetes was 10.34 years (interquartile range: 4.69-14.03 years). 172 cases of DR were screened, yielding a prevalence rate of 7.39% (167 with moderate non-proliferative DR, 3 with severe non-proliferative DR, and 2 with proliferative DR). The photographs captured by non-mydriatic fundus camera of three types were shown in Figure 1 (A: normal control, B: non-proliferative DR, C: proliferative DR). Specifically, there were 85 male and 87 female patients with DR. Among them, 148 were aged 60 and over, while 24 were under 60 years of age, with 1 individual younger than 30 years old. Notably, significant differences were observed between the T2DM group and the DR group in terms of diabetes duration, family history, history of hypoglycemia, glycated hemoglobin levels, sleep quality, MCI, hypertension, and eGDR distribution, as detailed in Table 1.

Figure 1
Three  retinal  images labeled A, B, and  C. Image  A shows a normal retina  with distinct  blood vessels.  Image  B displays  retinal  changes with pale  spots indicating possible abnormalities. Image  C shows more pronounced pale  areas, suggesting increased severity.

Figure 1. Photographs captured by non-mydriatic fundus camera of three types (A: normal control, B: non-proliferative DR, C: proliferative DR).

Table 1
www.frontiersin.org

Table 1. Comparison of basic characteristics between two groups of T2DM patients.

3.2 Association analysis between eGDR and DR

The RCS curve demonstrated a significant negative linear relationship between eGDR and DR (overall P < 0.05, non-linear P > 0.05), even after adjusting for covariates such as family history, history of hypoglycemia, sleep disorders, MCI, and disease duration, as illustrated in Figure 2.

Figure 2
Two graphs labeled A and  B, showing the  association between eGDR and  odds ratios  with 95% confidence intervals.  Both  graphs indicate a decreasing trend with shaded areas representing confidence intervals.  The p-value for overall in both graphs is less than  0.001.  The p-value for nonlinearity is 0.106  in A and  0.086 in B.

Figure 2. Dose-response relationship between eGDR and DR (A: without controlling covariates; B: with controlling covariates).

Regression model 1 was constructed with T2DM with or without DR as the dependent variable and eGDR as the independent variable to analyze their association. The results showed that for each increase of one SD in eGDR, the risk of DR was reduced by 42.5%. Subsequently, variables found to be significant in univariate analysis (family history, history of hypoglycemia, sleep disorders, MCI, and disease duration) were included as covariates, leading to the construction of regression model 2. The findings revealed that for each increase of one SD in eGDR, the risk of DR was reduced by 40.4%. When eGDR was divided into tertiles, in Model 1, compared to the third tertile group, the risk of DR in the first tertile group was 3.122-fold higher, and in the second tertile group, it was 1.731-fold higher. After adjusting for covariates, the risk of DR in the first tertile group was 2.965 times that of the third tertile group, while in the second tertile group, it was 1.729 times that of the third tertile group (Table 2).

Table 2
www.frontiersin.org

Table 2. Logistic regression results of the association between eGDR and DR.

3.3 Subgroup analysis

Subgroup analysis was conducted to assess the reliability of the regression association between eGDR and DR. Referring to previous studies, the subgroups included gender, age, smoking, drinking, and hyperlipidemia. The results in Table 3 showed that the association between eGDR and DR was robust and reliable in these subgroups (P > 0.05 for all subgroups).

Table 3
www.frontiersin.org

Table 3. Subgroup analysis of the association between eGDR and DR.

3.4 Predictive effect of eGDR on DR

The ROC curve analysis was conducted to assess the diagnostic performance of eGDR in identifying DR. When eGDR was incorporated into the model as a continuous variable, the area under the curve (AUC) was 0.781 (95%CI: 0.747-0.815, P < 0.001). When eGDR was included as a categorical variable, the AUC was 0.777 (95%CI:0.743-0.811, P < 0.001), as illustrated in Figure 3. These results indicated that eGDR demonstrated substantial diagnostic accuracy for DR.

Figure 3
ROC curve  displaying  sensitivity  versus  one minus  specificity. The blue  line represents eGDR as a categorical variable,  the  red  line represents eGDR as a continuous variable,  and  the  green line is the  line of reference.

Figure 3. ROC curve analysis of eGDR for DR.

4 Discussion

Our study revealed a DR prevalence of 7.39% in Pudong New Area, and there was a significant negative linear relationship between eGDR and DR risk. Specifically, each standard deviation increase in eGDR was associated with a 40.4% reduction in DR risk.

With the increasing prevalence of T2DM, the disease burden of DR has escalated sharply by 25% over the past decade, leading to a continuous rise in visual impairment and associated care requirements (16). Research indicates that the accuracy of automated fundus examination for DR detection reaches 93%, with the performance of artificial intelligence systems being comparable to that of retinal experts in classifying DR (17, 18). In our study, the prevalence of DR was 7.39%, lower than that observed in northern cities in China, such as Harbin and Shijiazhuang (14, 15), potentially attributable to the ongoing integration of diabetes medical treatment and health management services in Shanghai (19), which has facilitated earlier detection and referral of DR patients. Although previous studies suggested that women exhibit a higher susceptibility to DR, and the association between eGDR and DR was more pronounced in this group (1420), no significant gender differences were identified in our investigation.

The screening of DR has been integrated into the community-based management of diabetic patients since 2018. Given the cognitive impairments associated with DR, along with the necessity for specialized fundus examination equipment and professional ophthalmologists to interpret the results, DR is frequently diagnosed at a moderate non-proliferative stage. Therefore, it is imperative to conduct a fundus examination immediately upon diagnosis of T2DM. Early intervention is particularly critical for patients with a family history of DR, a history of hypoglycemia, prolonged disease duration, poor glycemic control, hypertension, sleep disorders, and cognitive impairment to prevent vision loss.

IR represents a hallmark pathological characteristic in diabetic patients. The gold standard for quantifying IR is hyperinsulinemic-euglycemic clamp technique. However, this method is invasive and time-consuming, thereby limiting its applicability in clinical and epidemiological studies. Recently, eGDR, an index derived from waist circumference, glycated hemoglobin, and hypertension, has emerged as a reliable substitute indicator. Studies have demonstrated that eGDR exhibits comparable accuracy to the hyperinsulinemic-euglycemic clamping. Furthermore, some research suggests that eGDR may serve as a valuable tool for predicting and managing cardiovascular and cerebrovascular diseases (21). Our study identified a significant linear relationship between eGDR and DR. After adjusting for relevant confounders, for each increase of one SD in eGDR, the risk of DR is reduced by 40.4%. When eGDR was categorized into percentile groups, compared to the third percentile group, the risk of DR in the first percentile group was 2.965-fold higher, while the risk in the second percentile group was 1.729 times. These findings align with previous studies, which have indicated that obesity, poor glycemic control, and hypertension are risk factors for DR (22, 23). Subgroup analysis revealed that the association between eGDR and DR remained unaffected by factors such as age, gender, smoking, drinking, and hyperlipidemia, demonstrating high diagnostic efficacy for DR. Therefore, our study supports the use of eGDR as a target for prediction and intervention of DR. Recently, some studies have found that non-invasive and rapid examinations, such as skin autofluorescence, have certain predictive value for the early diagnosis of DR (24). It is expected that more convenient and reliable indicators will be discovered to evaluate the occurrence and progression of DR.

The limitations of this study are as follows: (1) This is a cross-sectional study, and the follow-up of patients without DR will be conducted to further validate these findings; (2) The utilization of an artificial intelligence system for screening may result in potential missed diagnoses, which could lead to an underestimation of the true prevalence of DR. (3) Self-reported questionnaires might introduce information bias due to recall inaccuracies. (4) The sampling survey methodology might introduce bias into the findings.

5 Conclusion

The prevalence of DR among T2DM in Pudong New Area was 7.39%, and there was a significant negative linear correlation between eGDR and the risk of DR. It is anticipated that eGDR could serve as a potential target for predicting and intervening in DR.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by the Medical Ethics Committee of the Pudong New Area Center for Disease Control and Prevention (PDCDCLL-20220718-001). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

JG: Methodology, Software, Writing – original draft, Writing – review & editing. KW: Investigation, Software, Writing – original draft. XW: Investigation, Writing – review & editing. ZL: Investigation, Writing – review & editing. XL: Investigation, Writing – review & editing. JS: Investigation, Writing – review & editing. YL: Investigation, Writing – review & editing. HQ: Investigation, Writing – review & editing. FW: Investigation, Writing – review & editing. QX: Investigation, Writing – review & editing. SX: Investigation, Project administration, Writing – review & editing. YZ: Data curation, Project administration, Writing – review & editing. XR: Data curation, Methodology, Project administration, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. Funding for this article were supported by the Science and Technology Development Fund of Pudong New Area, Shanghai (PKJ2022-Y72), Pudong New Area Health System Leading Talents Training Program (PWRl2024-10), Investigator-initiated Clinical Research Project of the Pudong New Area Health Commission (2024-PWDL-03) and Business Research and Development Platform for Chronic Disease Epidemiology at the Pudong New Area Center for Disease Control and Prevention (DXZB-2024-01).

Acknowledgments

The authors would to express sincere gratitude to the Community Health Service Centers of Lujiazui, Huamu, Tangqiao, Zhoujiadu, Sanlin, Sanlin Kangde, Caolu, Gaodong, Shanggang, Hudong, Heqing, Liuzao, Airport, Jiangzhen, Xinchang, Shuyuan, and Datuan, as well as Yangsi Hospital, for their comprehensive support during the investigation.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. (2021) 128:1580–91. doi: 10.1016/j.ophtha.2021.04.027

PubMed Abstract | Crossref Full Text | Google Scholar

2. Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. (2018) 102:575–85. doi: 10.1136/bjophthalmol-2017-311258

PubMed Abstract | Crossref Full Text | Google Scholar

3. Zhang R, Dong L, Fu X, Hua L, Zhou W, Li H, et al. Trends in the prevalence of common retinal and optic nerve diseases in China: an artificial intelligence based national screening. Transl Vis Sci Technol. (2024) 13:28. doi: 10.1167/tvst.13.4.28

PubMed Abstract | Crossref Full Text | Google Scholar

4. Zhu RY, Ma QQ, Liu M, Zhuang HD, Teng B, Jiang XL, et al. Investigation on cognition of retinopathy and willingness of ophthalmic health examination in elderly patients with diabetes. Geriatr Health Care. (2024) 30:1094–1098 + 1105. doi: 10.3969/j.issn.1008-8296.2024.04.040

Crossref Full Text | Google Scholar

5. Zhu X, Xu Y, Xu X, Zhu J, He X, Lu L, et al. Psychometric assessment and application of the Chinese version of the Compliance with Annual Diabetic Eye Exams Survey in people with diabetic retinopathy. Diabetes Med. (2020) 37:84–94. doi: 10.1111/dme.14092

PubMed Abstract | Crossref Full Text | Google Scholar

6. Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: A scientific statement from the american heart association. Circulation. (2020) 141:e779–806. doi: 10.1161/CIR.0000000000000766

PubMed Abstract | Crossref Full Text | Google Scholar

7. Zhang Z, Zhao L, Lu Y, Xiao Y, and Zhou X. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. (2024) 23:194. doi: 10.1186/s12933-024-02256-5

PubMed Abstract | Crossref Full Text | Google Scholar

8. Peng J, Zhang Y, Zhu Y, Chen W, Chen L, Ma F, et al. Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study. BMC Med. (2024) 22:411. doi: 10.1186/s12916-024-03582-x

PubMed Abstract | Crossref Full Text | Google Scholar

9. Meng C, Xing Y, Huo L, and Ma H. Relationship between estimated glucose disposal rate and type 2 diabetic retinopathy. Diabetes Metab Syndr Obes. (2023) 16:807–18. doi: 10.2147/DMSO.S395818

PubMed Abstract | Crossref Full Text | Google Scholar

10. Xu YX, Pu SD, Zhang YT, Tong XW, Sun XT, Shan YY, et al. Insulin resistance is associated with the presence and severity of retinopathy in patients with type 2 diabetes. Clin Exp Ophthalmol. (2024) 52:63–77. doi: 10.1111/ceo.14344

PubMed Abstract | Crossref Full Text | Google Scholar

11. Fundus Disease Group of Ophthalmological Society of Chinese Medical Association, Fundus Disease Group of Ophthalmologist Branch of Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022). Chin J Ocul Fundus Dis. (2023) 2:99–124. doi: 10.3760/cma.j.cn511434-20230110-00018

Crossref Full Text | Google Scholar

12. Chen J, Chen X, Mao R, Fu Y, Chen Q, Zhang C, et al. Hypertension, sleep quality, depression, and cognitive function in elderly: A cross-sectional study. Front Aging Neurosci. (2023) 15:1051298. doi: 10.3389/fnagi.2023.1051298

PubMed Abstract | Crossref Full Text | Google Scholar

13. Chen KL, Xu Y, Chu AQ, Ding D, Liang XN, Nasreddine ZS, et al. Validation of the chinese version of montreal cognitive assessment basic for screening mild cognitive impairment. J Am Geriatr Soc. (2016) 64:e285–90. doi: 10.1111/jgs.14530

PubMed Abstract | Crossref Full Text | Google Scholar

14. Cleland CL, Hunter RF, Kee F, Cupples ME, Sallis JF, and Tully MA. Validity of the global physical activity questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour. BMC Public Health. (2014) 14:1255. doi: 10.1186/1471-2458-14-1255

PubMed Abstract | Crossref Full Text | Google Scholar

15. You Y, Chen Y, Fang W, Li X, Wang R, Liu J, et al. The association between sedentary behavior, exercise, and sleep disturbance: A mediation analysis of inflammatory biomarkers. Front Immunol. (2023) 13:1080782. doi: 10.3389/fimmu.2022.1080782

PubMed Abstract | Crossref Full Text | Google Scholar

16. Tan TE and Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). (2023) 13:1077669. doi: 10.3389/fendo.2022.1077669

PubMed Abstract | Crossref Full Text | Google Scholar

17. Fung TH, Patel B, Wilmot EG, and Amoaku WM. Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond). (2022) 22:112–6. doi: 10.7861/clinmed.2021-0792

PubMed Abstract | Crossref Full Text | Google Scholar

18. Gu C, Wang Y, Jiang Y, Xu F, Wang S, Liu R, et al. Application of artificial intelligence system for screening multiple fundus diseases in Chinese primary healthcare settings: a real-world, multicentre and cross-sectional study of 4795 cases. Br J Ophthalmol. (2024) 108:424–31. doi: 10.1136/bjo-2022-322940

PubMed Abstract | Crossref Full Text | Google Scholar

19. Cai C, Liu Y, Li Y, Shi Y, Zou H, Bao Y, et al. Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM). Front Med. (2022) 16:126–38. doi: 10.1007/s11684-021-0897-7

PubMed Abstract | Crossref Full Text | Google Scholar

20. Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females with type 2 diabetes mellitus are prone to diabetic retinopathy: A twelve-province cross-sectional study in China. J Diabetes Res. (2020) 2020:5814296. doi: 10.1155/2020/5814296

PubMed Abstract | Crossref Full Text | Google Scholar

21. Ren X, Jiang M, Han L, and Zheng X. Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study. BMC Geriatr. (2022) 22:968. doi: 10.1186/s12877-022-03689-x

PubMed Abstract | Crossref Full Text | Google Scholar

22. Wang Q, Zeng N, Tang H, Yang X, Yao Q, Zhang L, et al. Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model. Front Endocrinol (Lausanne). (2022) 13:993423. doi: 10.3389/fendo.2022.993423

PubMed Abstract | Crossref Full Text | Google Scholar

23. Ghamdi AHA. Clinical predictors of diabetic retinopathy progression; A systematic review. Curr Diabetes Rev. (2020) 16:242–7. doi: 10.2174/1573399815666190215120435

PubMed Abstract | Crossref Full Text | Google Scholar

24. Martínez-García I, Cavero-Redondo I, Álvarez-Bueno C, Pascual-Morena C, Gómez-Guijarro MD, and Saz-Lara A. Non-invasive skin autofluorescence as a screening method for diabetic retinopathy. Diabetes Metab Res Rev. (2024) 40:e3721. doi: 10.1002/dmrr.3721

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: diabetic retinopathy, prevalence, insulin resistance, estimated glucose disposal rate, predictive value

Citation: Gao J, Wu K, Wang X, Li Z, Liu X, Song J, Liu Y, Qiu H, Wei F, Xu Q, Xiao S, Zhou Y and Ruan X (2025) Study on the prevalence of diabetic retinopathy in Pudong New Area and the predictive value of estimated glucose disposal rate: a cross-sectional study. Front. Endocrinol. 16:1571488. doi: 10.3389/fendo.2025.1571488

Received: 21 February 2025; Accepted: 10 June 2025;
Published: 25 June 2025.

Edited by:

Mohammad Irshad, Dasman Diabetes Institute, Kuwait

Reviewed by:

Irfan Ahmad, Genomic Science Academy, India
Pir Salim Mahar, Aga Khan University, Pakistan
Silvana Patiño-Cardona, University of Castilla La Mancha, Spain

Copyright © 2025 Gao, Wu, Wang, Li, Liu, Song, Liu, Qiu, Wei, Xu, Xiao, Zhou and Ruan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yi Zhou, eWl6aG91NTE3QDE2My5jb20=; Xiaonan Ruan, eG5ydWFuQHBkY2RjLnNoLmNu

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.